MedPath
NMPA Approval

Ropinirole Hydrochloride Sustained-release Tablets

国药准字HJ20150424

August 10, 2020

H20150424

Drug Information

盐酸罗匹尼罗缓释片

片剂

8mg

化学药品

August 10, 2020

August 9, 2025

Company Information

Applicant Company

GLAXOSMITHKLINE SA

Severo Ochoa,2 28760-TRES CANTOS(MADRID), SPAIN

Manufacturing Company

glaxo wellcome, s.a.

Avda.de Extremadura,no 3 09400-ARANDA DE DUERO (BURGOS) Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸罗匹尼罗缓释片 - NMPA 批准文号 | MedPath